Nephros, Inc. (NEPH) Tops Q4 EPS by 5c

Nephros, Inc. (NASDAQ: NEPH) reported Q4 EPS of $0.03, $0.05 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $3.57 million.

For earnings history and earnings-related data on Nephros, Inc. (NEPH) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Selloff in this renewable energy stock is overdone, BofA says
• Regional Management (RM) Reiterated at Market Outperform by Citizens After Price Reset